Market Overview:
The global diosmin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic diseases, increasing awareness about the benefits of diosmin, and growing demand for natural ingredients in dietary supplements. However, stringent regulatory framework governing the use of diosmin may restrain the growth of this market during the forecast period. On basis on type, powder segment is anticipated to hold major share in global diosmin market over next 10 years owing its properties including easy handling and storage along with longer shelf life as compared to granular form. On basis on application, prescription medicine segment is projected witness highest CAGR over next decade due high adoption rate by consumers for various medical conditions such as venous leg ulcers and hemorrhoids treatment across globe.
Product Definition:
Diosmin is a flavonoid glycoside found in citrus fruits, which has been shown to possess anti-inflammatory and antioxidant properties.
Powder:
Diosmin is a type of natural organic compound, first isolated from the plant roots in 1808. Diosmin is commercially available as white crystalline powder and has a strong odor similar to that of fresh mint. It is soluble in water and ethanol, but not in diethyl ether or acetone.
Granular:
Granular is a crystalline powder, which is used as an active ingredient in diosmin-based pharmaceuticals. It has a molecular weight of 132 and is soluble in water. Granular also contains some impurities such as residual monoclonal antibodies (mAb), amino acids, phenolic compounds, proteins and other minor components like lactose & minerals.
Application Insights:
The other application segment includes the dioic acid market which is anticipated to grow at a CAGR of XX% from 2018 to 2030 owing to its wide range of applications in various industries such as pharmaceuticals, cosmetics, and food additives. Diosmin has been used for centuries in traditional medicine as an anti-inflammatory agent and antiseptic for treating wounds. The compound also possesses antioxidant properties which are expected to drive demand over the forecast period.
Diosmin is widely utilized in the manufacture of nutritional supplements on account of its health benefits including weight management, cardiovascular support, gastrointestinal support (antimicrobial action), brain function improvement (antioxidants) and skin health improvement (anti-inflammatory). The product plays a significant role in several prescription medicines due to its antibacterial property against several types of bacteria including Staphylococcus aureus, Escherichia coli O157:H7., Klebsiella pneumoniae.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness considerable growth over the forecast period owing to rising product demand as a result of increasing aging population and prevalence of chronic diseases, such as cancer, diabetes, arthritis, and cardiovascular diseases. In addition, high adoption rate of dietary supplements is also expected to drive regional market growth over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the same period owing to rapid economic development coupled with growing health awareness among consumers in emerging countries including China and India. Increasing disposable income levels are also contributing toward increased product consumption in this region which will further boost industry expansion prospects during the projected time frame.
Growth Factors:
- Increasing awareness about the health benefits of diosmin is expected to drive the market growth.
- Rising prevalence of chronic diseases such as cancer, heart disease, and diabetes is anticipated to fuel the demand for diosmin supplements over the forecast period.
- Growing geriatric population is also projected to boost the demand for diosmin products as these individuals are more susceptible to chronic diseases.
- Increasing research and development activities for new applications of diosmin is likely to create opportunities for market growth in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diosmin Market Research Report
By Type
Powder, Granular
By Application
Prescription Medicine, Nutritional Supplement, Other
By Companies
Shanghai Freemen, Interquim, Bannerbio, Suan Farma, N?R Bio Industries, Penam Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Diosmin Market Report Segments:
The global Diosmin market is segmented on the basis of:
Types
Powder, Granular
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Prescription Medicine, Nutritional Supplement, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shanghai Freemen
- Interquim
- Bannerbio
- Suan Farma
- N?R Bio Industries
- Penam Laboratories
Highlights of The Diosmin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Granular
- By Application:
- Prescription Medicine
- Nutritional Supplement
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diosmin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diosmin is a natural compound found in plants. It has been shown to have anti-inflammatory and antioxidant properties.
Some of the key players operating in the diosmin market are Shanghai Freemen, Interquim, Bannerbio, Suan Farma, N?R Bio Industries, Penam Laboratories.
The diosmin market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diosmin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diosmin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diosmin Market - Supply Chain
4.5. Global Diosmin Market Forecast
4.5.1. Diosmin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diosmin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diosmin Market Absolute $ Opportunity
5. Global Diosmin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diosmin Market Size and Volume Forecast by Type
5.3.1. Powder
5.3.2. Granular
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diosmin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diosmin Market Size and Volume Forecast by Application
6.3.1. Prescription Medicine
6.3.2. Nutritional Supplement
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diosmin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diosmin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diosmin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diosmin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diosmin Demand Share Forecast, 2019-2026
9. North America Diosmin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diosmin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diosmin Market Size and Volume Forecast by Application
9.4.1. Prescription Medicine
9.4.2. Nutritional Supplement
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diosmin Market Size and Volume Forecast by Type
9.7.1. Powder
9.7.2. Granular
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diosmin Demand Share Forecast, 2019-2026
10. Latin America Diosmin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diosmin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diosmin Market Size and Volume Forecast by Application
10.4.1. Prescription Medicine
10.4.2. Nutritional Supplement
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diosmin Market Size and Volume Forecast by Type
10.7.1. Powder
10.7.2. Granular
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diosmin Demand Share Forecast, 2019-2026
11. Europe Diosmin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diosmin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diosmin Market Size and Volume Forecast by Application
11.4.1. Prescription Medicine
11.4.2. Nutritional Supplement
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diosmin Market Size and Volume Forecast by Type
11.7.1. Powder
11.7.2. Granular
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diosmin Demand Share, 2019-2026
12. Asia Pacific Diosmin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diosmin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diosmin Market Size and Volume Forecast by Application
12.4.1. Prescription Medicine
12.4.2. Nutritional Supplement
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diosmin Market Size and Volume Forecast by Type
12.7.1. Powder
12.7.2. Granular
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diosmin Demand Share, 2019-2026
13. Middle East & Africa Diosmin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diosmin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diosmin Market Size and Volume Forecast by Application
13.4.1. Prescription Medicine
13.4.2. Nutritional Supplement
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diosmin Market Size and Volume Forecast by Type
13.7.1. Powder
13.7.2. Granular
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diosmin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diosmin Market: Market Share Analysis
14.2. Diosmin Distributors and Customers
14.3. Diosmin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Shanghai Freemen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Interquim
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bannerbio
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Suan Farma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. N?R Bio Industries
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Penam Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
